Provided by Tiger Fintech (Singapore) Pte. Ltd.

RAPT Therapeutics, Inc.

0.8744
+0.00981.13%
Post-market: 0.8619-0.0125-1.43%19:50 EDT
Volume:741.96K
Turnover:643.01K
Market Cap:115.43M
PE:-0.27
High:0.8886
Open:0.8600
Low:0.8106
Close:0.8646
Loading ...
Mar 07, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2023

Major Issues Report

Form 8-K - Current report
Oct 24, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Correspondence

Form CORRESP - Correspondence
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2023

Major Issues Report

Form 8-K - Current report